Ascendis Pharma A/S (ASND)
Last updated: 2026-10-20 21:00:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Ascendis Pharma A/S (ASND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $234.24, with a market capitalization of $14.82B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $186.05 to $282.15. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$14.82B | |
$230.19 | |
$282.15 | |
$11.92 | |
$229.95 | |
328.48K | |
693.55K | |
-- | |
$282.15 | |
$186.05 | |
-- | |
-- |
Ascendis Pharma A/S (ASND) After-Hours Stock Price
Ascendis Pharma A/S (ASND) is trading at $234.00 in after-hours trading as of 2026-10-20 20:47:00, up 1.76% ($4.05) from the regular-session close of $229.95.
After-hours trading shows how investors are pricing ASND after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Ascendis Pharma A/S (ASND) 7-Day Stock Price Change
Over the past seven days, Ascendis Pharma A/S (ASND) moved from $229.23 to $234.24, representing a gain of 2.19% ($5.01).
The stock traded between $222.00 and $235.45 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 774.79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ASND 52-Week Price Position
Position in Range: 50.1%
ASND is currently trading at $234.24, placing it 50.1% of the way from its 52-week low of $186.05 to its 52-week high of $282.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Ascendis Pharma A/S (ASND)?
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Ascendis Pharma A/S Information
| Employees | 1189 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Ascendis Pharma A/S (ASND) Stock on MEXC
Eligible investors can buy real shares of Ascendis Pharma A/S (ASND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Ascendis Pharma A/S (ASND) stock price today?
2.Is ASND stock going up or down today?
3.What is ASND pre-market price?
4.What is ASND after-hours price?
5.Is ASND stock trading now?
6.Where does ASND sit relative to its 52-week high and low?
7.What sector is Ascendis Pharma A/S in?
8.What is Ascendis Pharma A/S's market capitalization and where is it listed?
9.How is ASND valued in terms of P/E ratio and EPS?
10.Does Ascendis Pharma A/S pay a dividend?
Explore More US Stocks
Search Stocks
ASND Stock Calculator
Estimate the value between ASND shares and USD.
ASND Shares to USD
1.00 ASND shares = 234.24 USD
Calculations are estimates based on the latest available price and are for reference only.



